Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products".
Smith MY, Hammad TA, Metcalf M, Levitan B, Noel R, Wolka AM, Michaels DL, Johnson FR. Smith MY, et al. Ther Innov Regul Sci. 2016 Sep;50(5):546-553. doi: 10.1177/2168479016662902. Ther Innov Regul Sci. 2016. PMID: 30231755
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H; BRACE Special Interest Group. Radawski C, et al. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1233-40. doi: 10.1002/pds.3859. Epub 2015 Oct 12. Pharmacoepidemiol Drug Saf. 2015. PMID: 26456379 Review.
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.
Janssens R, Huys I, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, Ciaglia A, Simoens S, Stevens H, Smith M, Levitan B, Cleemput I, de Bekker-Grob E, Veldwijk J. Janssens R, et al. BMC Med Inform Decis Mak. 2019 Oct 4;19(1):189. doi: 10.1186/s12911-019-0875-z. BMC Med Inform Decis Mak. 2019. PMID: 31585538 Free PMC article.
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US.
Whichello C, van Overbeeke E, Janssens R, Schölin Bywall K, Russo S, Veldwijk J, Cleemput I, Juhaeri J, Levitan B, Kübler J, Smith M, Hermann R, Englbrecht M, Hueber AJ, Comanescu A, Harding S, Simoens S, Huys I, de Bekker-Grob EW. Whichello C, et al. Front Pharmacol. 2019 Sep 18;10:1009. doi: 10.3389/fphar.2019.01009. eCollection 2019. Front Pharmacol. 2019. PMID: 31619989 Free PMC article.
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.
Durosini I, Janssens R, Arnou R, Veldwijk J, Smith MY, Monzani D, Smith I, Galli G, Garassino M, Katz EG, Bailo L, Louis E, Vandevelde M, Nackaerts K, de Wit GA, Pravettoni G, Huys I. Durosini I, et al. Among authors: smith my, smith i. Front Public Health. 2021 Feb 5;9:622154. doi: 10.3389/fpubh.2021.622154. eCollection 2021. Front Public Health. 2021. PMID: 33634069 Free PMC article.
64 results